The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal published by Springer. It is the official journal of the European Association of Nuclear Medicine.[1] Since 1976, the EJNMMI has published material related to the field of nuclear medicine, including dosimetry, radiation biology, radiochemistry, radiopharmacology, molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression, and antisense methodologies. As of 2021, the EJNMMI has an impact factor of 10.057.[2]
 | |
| Discipline | Nuclear Medicine |
|---|---|
| Language | English |
| Edited by | Arturo Chiti |
| Publication details | |
| History | 1976-present |
| Publisher | |
| Frequency | Monthly |
| 9.236 (2020) | |
| Standard abbreviations | |
| ISO 4 | Eur. J. Nucl. Med. Mol. Imaging |
| Indexing | |
| CODEN | EJNMA6 |
| ISSN | 1619-7070 (print) 1619-7089 (web) |
| LCCN | 2002252212 |
| OCLC no. | 49348061 |
| Links | |
Spin off
editIn summer of 2011, Springer launched EJNMMI Research, a peer-reviewed open access journal, as a companion to the EJNMMI. It accommodates articles that could not be published in EJNMMI.
References
edit- ^ "European Association of Nuclear Medicine - EJNMMI". Eanm.org. Archived from the original on 2012-10-24. Retrieved 2012-11-01.
- ^ "European Journal of Nuclear Medicine and Molecular Imaging". Springer. Springer. Retrieved June 26, 2023.
External links
edit
  | This article about a medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |